Visceral Organs Research Articles

Overexpression of CD44 as a predictor of metastatic potential in patients with colorectal cancer

Objective. To correlate CD44 expression with the clinicopathological characteristics of patients with colorectal carcinoma (CRC).
 Materials and methods. This study included 90 patients with CRC who underwent curative surgical resection. Standard histopathological techniques and immunohistochemistry analysis was used to investigate CD44 expression. Semi–quantitative scoring was used to categorize CD44 expression levels. Patients' clinicopathological characteristics were retrospectively examined.
 Results. Overexpression of CD44 was found in 46.7% of all patients with CRC. Patients with right colon cancer had the highest CD44 expression (54,6%). Overexpression of CD44 was present in 69.6% of patients with metastatic lesions in visceral organs. We found statistically significant differences between CD44 overexpression and the presence of visceral metastases (p = 0.015), different T categories (p = 0.011), N status (p = 0.006), and G differentiation (p = 0.011). Our results showed that the disease stage has the greatest effect on CD44 overexpression (p <0.001).
 Conclusion. Overexpression of CD44 could be a reliable predictor of metastatic potential and poor prognosis in patients with CRC.

Evaluation of Pharmacokinetic and Pharmacodynamic (PK/PD) of Novel Fluorenylmethoxycarbonyl- Phenylalanine Antimicrobial Agent.

To assess the pharmacokinetic profile, in-vivo toxicity, and efficacy of 9-Fluorenylmethoxycarbonyl-L-phenylalanine (Fmoc-F) as a potential antibacterial agent, with a focus on its suitability for clinical translation. An RP-HPLC-based bio-analytical method was developed and qualified to quantify Fmoc-F levels in mouse plasma for pharmacokinetic analysis. Oral bioavailability was determined, and in-vivo toxicity was evaluated following intra-peritoneal administration. Efficacy was assessed by measuring the reduction in Staphylococcus aureus burden and survival rates in BALB/c mice. The RP-HPLC method is highly sensitive, detecting as low as 0.8µgmL-1 (~ 2µM) of Fmoc-F in blood plasma. This study revealed that Fmoc-F has an oral bioavailability of 65 ± 18% and suitable pharmacokinetic profile. Further, we showed that intra-peritoneal administration of Fmoc-F is well tolerated by BALB/c mice and Fmoc-F treatment (100mg/kg, i.p.) significantly reduces Staphylococcus aureus burden from visceral organs in BALB/c mice but falls short in enhancing survival rates at higher bacterial loads. The study provides crucial insights into the pharmacokinetic and pharmacodynamic properties of Fmoc-F. The compound displayed favourable oral bioavailability and in-vivo tolerance. Its significant reduction of bacterial burden underscores its potential as a treatment for systemic infections. However, limited effectiveness for severe infections, short half-life, and inflammatory response at higher doses need to be addressed for its clinical application.

Design, synthesis, and biological evaluation of eugenol-isoxazoline hybrid derivatives as potential anti-leishmanial agents

Leishmaniasis is a group of protozoan parasitic diseases caused by various Leishmania species. The clinical manifestations range from skin abrasions to lethal infection in the visceral organs such as the liver and spleen. The emergence of drug resistance, long hospitalization periods, and various adverse effects of the current therapeutic regimen have incited the quest for exploring novel molecules as efficient treatment regimens. Eugenol is the major component of clove essential oil and has significant biological potential with anti-microbial properties. Moreover, natural product derivatives having the isoxazoline group have shown promising pharmacological applications. Thus, various analogs were synthesized and characterized to explore the anti-leishmanial potency of eugenol and isoxazoline hybrid. Results from the in vitro assay against Leishmania donovani parasites identified three potent derivatives (7e, 8a, and 8b) with IC50 values in the range of 7–17 µM. Cytotoxicity analysis against the J774A.1 macrophage cell line confirmed the satisfactory safety index of these potent hits and ex vivo infectivity assay established the role of these hits in reducing intracellular amastigote burden. Next, various mechanistic studies, including SEM analysis, higher ROS production, reduced intracellular ATP levels, mitochondrial dysfunction, formation of intracellular lipid bodies, and acidic vesicular organelles, confirmed the role of these potent hits in parasite cell death. According to the molecular docking analysis results, the most potent derivative, 8b, had strong binding interactions with residues Ile296, Pro299, and Phe354 of sterol 14α-demethylase protein of the Leishmania parasite. Entirely the study highlights the role of eugenol-isoxazoline hybrid derivatives as potential leishmanicidal agents.

Congenital diseases with multi-organ expression as an indication for liver transplantation in children during the first years of life: Integrative approach to improve the outcomes

Pediatric liver transplantation has evolved since the first transplant was performed by Dr. Starzl more than 50 years ago. Innovations in surgical techniques, immunosuppression, and infection control have significantly improved patient outcomes, graft survival, and quality of life. However, further progress depends not only on the discovery of new treatment option but should rely upon the identification of the factors in the perioperative care which contribute to successful outcomes and guide our decision-making process.Indications for pediatric liver transplantation can be divided into three major groups: cholestatic liver conditions, liver based metabolic disorders, and others represented by acute liver failure of different etiologies, tumors, inherited autoimmune diseases, and multiple infectious causes.Many of these conditions manifest themselves with multi organ pathologic expression, requiring earlier interventions to treat acute liver failure or chronic cholestasis leading to failure to thrive. Containment of patient pathology and maintenance of optimal neurologic and extra-hepatic visceral organ function is paramount during the pre - transplant period.Multidisciplinary management of comorbid conditions in complex pediatric liver transplant candidates during the perioperative period with the emphases on optimization and patient selection has never been summarized in the literature. Thant is why this review focuses on a comprehensive, multidisciplinary preoperative evaluation of pediatric patients in whom progressive liver disfunction manifests early in life and eventually requires liver transplantation. We will address multi-organ system involvement, preoperative optimization in anticipation of the complexity of intraoperative care, as well as short- and long-term postoperative management.

Simultaneous erosion of gastric band into stomach and transverse colon

Laparoscopic adjustable banding was previously considered to be the safest and least invasive technique in bariatric surgery in the mid-1990s. It has since been performed less frequently as newer bariatric interventions and surgical techniques, and a fuller understanding of gastric banding complications have been elucidated. Nevertheless, there are a significant number of patients with in situ gastric bands, and cases of significant and unusual complications involving multiple visceral organs must be described and documented in order to enhance providers’ awareness and facilitate early recognition.

Delayed presentation of traumatic hepatothorax: An anesthetic and surgical perspective

: Traumatic diaphragmatic hernia is an uncommon sequela of blunt and penetrating trauma. It is estimated that 0.8–1.6% of patients with blunt trauma develop diaphragmatic rupture. However, the diagnosis of this condition is often overlooked, with right-sided hernias missed more frequently than left-sided hernias. Early diagnosis and repair are essential to prevent future complications such as strangulation and ischemia of intra-abdominal organs, lung collapse, and cardiovascular demise.: A 17-year-old male (180 cm; 86 kg) with no comorbidities presented to the emergency department (ED) following a high-velocity, unrestricted, rear-ended motor vehicle crash (MVC). The patient was intubated and hemodynamically stabilized in the ED, with planned surgical exploration of the abdomen. Six days following the accident, the patient was extubated; he became increasingly hypoxic and tachypneic over the next day. A CT of the chest and pelvis was ordered, confirming the diagnosis of a post-traumatic right-sided diaphragmatic hernia. An exploratory laparotomy was scheduled. Difficulties with ventilation were encountered due to suspected lung compression by the liver and movement of the endotracheal tube into the right main lung bronchus. : Traumatic diaphragmatic hernia should be considered in all patients presenting with abdominal trauma and should be suspected if respiratory distress arises during the patient’s clinical course. The recommended anesthetic approach is rapid sequence intubation with a cardiovascular-stable agent like etomidate and gastric decompression. Difficulties with intubation and ventilation should be anticipated due to the presence of the visceral organs within the thoracic cavity.

The Crosstalk between N-Formyl Peptide Receptors and uPAR in Systemic Sclerosis: Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities.

Systemic Sclerosis (SSc) is a heterogeneous autoimmune disease characterized by widespread vasculopathy, the presence of autoantibodies and the progressive fibrosis of skin and visceral organs. There are still many questions about its pathogenesis, particularly related to the complex regulation of the fibrotic process, and to the factors that trigger its onset. Our recent studies supported a key role of N-formyl peptide receptors (FPRs) and their crosstalk with uPAR in the fibrotic phase of the disease. Here, we found that dermal fibroblasts acquire a proliferative phenotype after the activation of FPRs and their interaction with uPAR, leading to both Rac1 and ERK activation, c-Myc phosphorylation and Cyclin D1 upregulation which drive cell cycle progression. The comparison between normal and SSc fibroblasts reveals that SSc fibroblasts exhibit a higher proliferative rate than healthy control, suggesting that an altered fibroblast proliferation could contribute to the initiation and progression of the fibrotic process. Finally, a synthetic compound targeting the FPRs/uPAR interaction significantly inhibits SSc fibroblast proliferation, paving the way for the development of new targeted therapies in fibrotic diseases.

Intramarginal Excision of Keloid with Application of Kshara Taila

The destruction/ break/ rupture/ discontinuity of body/tissue/ part of body is called “Vrana”. The definition of Granthi is very well described by Acharya Vagbhata and Acharya Sushruta which seems to be more or less the same. According to Vagbhata, Malas (Doshas) of which Kapha being predominant, vitiating the Medas (fat), Mamsa (muscle) and Asra (blood) gets localised in these tissues and produce a round elevated growth, compact in nature which is called Granthi. Acharya Sushruta has explained that “the scars of a wound never disappear even after complete healing and its imprint persists lifelong and it is called Vrana. This phenomenon of Vrana is not only limited to cutaneous lesion but may also extend upto muscles blood vessels, ligaments, bones, joints, visceral organs and other vital parts of body. According to Sushruta, Granthi is a Vrita (round), Unnata (elevated), Vigrathita (hard) swelling by pathological involvement of Mansa, Rakta and Meda. Modern science compares Vranagranthi to keloid. It is a tumour arising from fibro proliferative disorders of the dermis. The main phenomenon is the excessive deposition of extracellular matrix proteins, which is composed by collagen fibres. It develops exclusively in humans. There is no proven, efficient treatment for keloid. This case study will lead to the development of new and improved keloid treatment methods.

Rodent-borne parasites in Qatar: A possible risk at the human-animal-ecosystem interface

Rodents are known reservoirs for a diverse group of zoonotic pathogens that can pose a threat to human health. Therefore, it is crucial to investigate these pathogens to institute prevention and control measures. To achieve this, the current study was conducted to investigate the frequency of different parasites in commensal rodents in Qatar. A total of 148 rodents, including Rattus norvegicus, Rattus rattus, and Mus musculus were captured using traps placed in different habitats such as agricultural and livestock farms, residential areas, and other localities. Blood, feces, ectoparasite, and visceral organs were collected for gross, microscopic, immunological, and molecular analysis. The study identified 10 different parasites, including Capillaria annulosa, Eimeria spp., Giardia spp., Hymenolepis diminuta, Mastophorus muris, Ornithonyssus bacoti, Taenia taeniaeformis, Toxoplasma gondii, Trypanosoma lewisi, and Xenopsylla astia. Overall, 62.2% of the rodents tested positive for at least one parasite species. Helminths were found to be the most prevalent parasites (46.0%), followed by ectoparasites (31.8%), and protozoa (10.1%). However, individually, X. astia was the most prevalent (31.8%), whereas C. annulosa was the least common (0.7%). The prevalence of X. astia and H. diminuta significantly differed between habitats (p < 0.05). The sequence analysis of Hymenolepis spp. was closely related to the previously reported H. diminuta in Iran, China, and Mexico. In conclusion, the study identified a diverse range of rodent-borne parasites that are important to public health, with most of them being recorded for the first time among commensal rodents in Qatar.

Intra-Abdominal Epithelioid Neoplasm With EWSR1::CREB Fusions Involving the Kidney: A Clinicopathologic and Molecular Characterization With an Emphasis on Differential Diagnosis

Soft tissue neoplasms, harboring fusions between EWSR1 and FUS with genes encoding CREB transcription factors family (ATF1, CREB1, and CREM), are an emerging heterogeneous group of mesenchymal tumors that differ significantly in morphology, immunophenotypes, and behavior. Recently, EWSR1/FUS::CREB fusions have been recognized to define a group of aggressive neoplasms of epithelioid morphology with multiple growth patterns and a striking predilection for mesothelial-lined cavities. These neoplasms presenting as a primary neoplasm of intra-abdominal visceral organs are rare, which could elicit a wide range of differential diagnoses because of their diverse morphologies and immunohistochemical profiles. We report 3 cases of intra-abdominal epithelioid neoplasms with EWSR1::CREB fusions involving the kidney. This study included 2 female patients and 1 male patient, with age at presentation ranging from 17 to 61 years (mean: 32 years). All the patients underwent radical nephrectomy without adjunctive therapies. Grossly, the tumors were large, and all were solitary masses with sizes ranging from 5.6 to 30.0 cm (mean: 14.5 cm). Histologically, the neoplasms showed infiltrating and indistinct borders and were composed predominantly of monomorphic round-to-epithelioid cells with variable amounts of pale-to-clear cytoplasm, arranged in cords, nests, and sheets and embedded in a sclerotic hyalinized stroma with variable lymphoid cuffing either intermixed or at the periphery. Notably, a hemangiopericytomatous growth pattern was commonly seen. Nuclear atypia was mild, and mitotic activity was scarce. Immunohistochemically, all 3 cases were at least focally positive for epithelial membrane antigen and keratin AE1/AE3, with 2 tumors showing focal MUC4 expression and 1 case displaying diffuse CD34 and focal CAIX positivity. Targeted RNA sequencing identified EWSR1::CREM fusion in 2 cases and EWSR1::ATF1 fusion in 1 case. Subsequent fluorescence in situ hybridization analysis confirmed the RNA sequencing results. On follow-up, 1 patient developed multiple spinal bone metastases 5 months after the surgery while the other 2 patients were free of disease 9 and 120 months after diagnosis, respectively. Our findings demonstrate that intra-abdominal epithelioid neoplasms with EWSR1::CREB fusions may rarely occur primarily in the kidney and should be included in the differential diagnosis of primary renal epithelioid mesenchymal neoplasms.

Revealing mitf functions and visualizing allografted tumor metastasis in colorless and immunodeficient Xenopus tropicalis

Transparent immunodeficient animal models not only enhance in vivo imaging investigations of visceral organ development but also facilitate in vivo tracking of transplanted tumor cells. However, at present, transparent and immunodeficient animal models are confined to zebrafish, presenting substantial challenges for real-time, in vivo imaging studies addressing specific biological inquiries. Here, we employed a mitf−/−/prkdc−/−/il2rg−/− triple-knockout strategy to establish a colorless and immunodeficient amphibian model of Xenopus tropicalis. By disrupting the mitf gene, we observed the loss of melanophores, xanthophores, and granular glands in Xenopus tropicalis. Through the endogenous mitf promoter to drive BRAFV600E expression, we confirmed mitf expression in melanophores, xanthophores and granular glands. Moreover, the reconstruction of the disrupted site effectively reinstated melanophores, xanthophores, and granular glands, further highlighting the crucial role of mitf as a regulator in their development. By crossing mitf−/− frogs with prkdc−/−/il2rg−/− frogs, we generated a mitf−/−/prkdc−/−/il2rg−/−Xenopus tropicalis line, providing a colorless and immunodeficient amphibian model. Utilizing this model, we successfully observed intravital metastases of allotransplanted xanthophoromas and migrations of allotransplanted melanomas. Overall, colorless and immunodeficient Xenopus tropicalis holds great promise as a valuable platform for tumorous and developmental biology research.

Study on the adoption of an artificial intelligence algorithm for the automatic segmentation of visceral organs.

The study aimed to automate CT organ segmentation using image processing and machine learning. The process involved data acquisition, labeling, neural network training, validation, testing, segmentation, analysis, interpretation, feedback, improvement, documentation, and sharing. Analyzing 20 anonymized patients on two high-performance workstations, segmenting thoraco-abdominal regions, liver, and spleen using 3D SLICER and plugins. Repeatability tests using "Autodesk Meshmixer" and "Prusa Slicer" revealed workstation 2 took nearly three times longer in 'fast' mode and 13 times longer in 'normal' mode compared to workstation 1. In conclusion, the study explored AI for organ segmentation, showing efficiency and potential cost reduction. Legal, ethical, and technical challenges include privacy concerns, professional responsibility, and the need for annotated data. Interoperability, adaptability, staff training, and continuous monitoring are crucial for AI effectiveness and safety in clinical settings. Despite challenges, AI proves valuable for precise, timely medicine, supporting medical personnel.

Expression of IZUMO1 and JUNO in the gonads of domestic cats (Felis catus)

Because of the time-consuming nature of surgical neutering and the rapid rate of reproduction among domestic cats, it is crucial to investigate alternative, nonsurgical methods of contraception for this species. Sperm protein IZUMO1 and its oocyte receptor JUNO have been proposed as potential targets for nonsurgical contraceptives. This study aimed to demonstrate (1) the protein coding sequence of feline IZUMO1 and JUNO, (2) gene expression in specific organs by measuring mRNA levels in different visceral tissues, and (3) the expression of IZUMO1 and JUNO during sperm maturation and folliculogenesis, respectively. Amplification for sequencing of feline IZUMO1 and JUNO was performed using the RT-PCR method. Levels of gene expression in different tissues were evaluated using real-time PCR. In situ hybridization was performed to localize JUNO mRNA in ovarian tissues. The complete coding sequences of IZUMO1 and JUNO were obtained and analyzed. A comparison between protein orthologs demonstrated the conservation of IZUMO1 and JUNO in Felidae. The real-time PCR results from various visceral organs indicated that IZUMO1 was significantly higher in the testis than in other organs, whereas JUNO was significantly higher in the ovary than in other organs. Expression of IZUMO1 was found to be higher in the testes than in the caput, corpus, and cauda of epididymides. In situ hybridization revealed that JUNO mRNA was in the ooplasm and nucleus of the primordial, primary, secondary, and antral follicles. Importantly, this was the first study to demonstrate the IZUMO1 and JUNO genes in the testis and ovary of cats. The results are useful for future research related to these genes and for developing contraceptives against these targets.

Unusual Sites of Visceral Spread in Prostate Cancer: A Prostate-Specific Membrane Antigen-Based Theranostic Imaging Series.

Prostate cancer commonly metastasizes to lymphatic and skeletal systems with lesser frequency to visceral organs; however, uncommon visceral sites have also been found and reported as case reports. We present a series of uncommon metastatic visceral spread in prostate cancer on prostate-specific membrane antigen-based diagnostic and posttherapeutic imaging modalities.

Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment.

The need for an interval between the administration of long-acting Somatostatin Receptor Analogues (SSA) and the [68Ga]Ga-DOTA-TATE PET has been questioned based on recent literature in the new EANM guidelines. Here an earlier studies showed that SSA injection immediately before SSTR PET had minimal effect on normal organ and tumor uptake (1). However, data are scarce and there are (small) differences between [68Ga]Ga-DOTA-TATE and [68Ga]Ga-DOTA-TOC binding affinity, and it remains unknown whether these findings can be directly translated to scans with [68Ga]Ga-DOTA-TOC as well. The purpose of this study was to assess the effect of SSA use on the biodistribution in a subsequent [68Ga]Ga-DOTA-TOC PET/CT and compare this intra-individually across several cycles of SSA treatments. Retrospectively, 35 patients with NENs were included. [68Ga]Ga-DOTA-TOC PET at staging and after the 1st and 2nd cycle of SSA were included. SUVmean and SUVmax of blood, visceral organs, primary tumor and two metastases were determined. Also, the interval between SSA therapy and the PET scan was registered. Treatment with SSA resulted in a significantly higher bloodpool activity and lower visceral tracer uptake. This effect was maintained after a 2nd cycle of SSA therapy. Furthermore, there was an inverse relationship between bloodpool tracer availability and visceral tracer binding and a positive correlation between bloodpool tracer availability and primary tumor tracer uptake. With an interval of up to 5days, there was a significantly higher bloodpool activity than at longer intervals. Absolute comparison of the SUV on [68Ga]Ga-DOTA-TOC PET should be done with caution as the altered biodistribution of the tracer after SSA treatment should be taken into account. We recommend not to perform a scan within the first 5days after the injection of lanreotide.

The bacterial pathogen Pseudomonas plecoglossicida, its epidemiology, virulence factors, vaccine development, and host-pathogen interactions.

Pseudomoans plecoglossicida has been identified as a fish pathogen since 2000 and has caused serious infections in cultured Large Yellow Croakers Larimiththys crocea in coastal eastern China during recent years. Published literatures of this pathogen have been reviewed. Several strains with high genomic similarity have been isolated and identified; the bacteria induce natural infection at lower water temperatures (12.0-25.5°C) and induce numerous granulomas and nodules in the visceral organs of croakers. Researchers have investigated the epidemiology of P. plecoglossicida infection, identified major virulence factors, searched for pathogenic genes, analyzed host-pathogen interactions, and endeavored to develop efficient vaccines. This paper provides an overview of these research advances to elucidate the virulence mechanisms of the pathogen and to promote vaccine development against infection.

Efficacy of a Combination Therapy with Laronidase and Genistein in Treating Mucopolysaccharidosis Type I in a Mouse Model.

Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disorder caused by α-L-iduronidase deficiency. The standard treatment, enzyme replacement therapy with laronidase, has limited effectiveness in treating neurological symptoms due to poor blood-brain barrier penetration. An alternative is substrate reduction therapy using molecules, such as genistein, which crosses this barrier. This study evaluated the effectiveness of a combination of laronidase and genistein in a mouse model of MPS I. Over 12 weeks, MPS I and wild-type mice received laronidase, genistein, or both. Glycosaminoglycan (GAG) storage in visceral organs and the brain, its excretion in urine, and the serum level of the heparin cofactor II-thrombin (HCII-T) complex, along with behavior, were assessed. The combination therapy resulted in reduced GAG storage in the heart and liver, whereas genistein alone reduced the brain GAG storage. Laronidase and combination therapy decreased liver and spleen weights and significantly reduced GAG excretion in the urine. However, this therapy negated some laronidase benefits in the HCII-T levels. Importantly, the combination therapy improved the behavior of female mice with MPS I. These findings offer valuable insights for future research to optimize MPS I treatments.

Accelerating neurotechnology development using an Agile methodology.

Novel bioelectronic medical devices that target neural control of visceral organs (e.g., liver, gut, spleen) or inflammatory reflex pathways are innovative class III medical devices like implantable cardiac pacemakers that are lifesaving and life-sustaining medical devices. Bringing innovative neurotechnologies early into the market and the hands of treatment providers would benefit a large population of patients inflicted with autonomic and chronic immune disorders. Medical device manufacturers and software developers widely use the Waterfall methodology to implement design controls through verification and validation. In the Waterfall methodology, after identifying user needs, a functional unit is fabricated following the verification loop (design, build, and verify) and then validated against user needs. Considerable time can lapse in building, verifying, and validating the product because this methodology has limitations for adjusting to unanticipated changes. The time lost in device development can cause significant delays in final production, increase costs, and may even result in the abandonment of the device development. Software developers have successfully implemented an Agile methodology that overcomes these limitations in developing medical software. However, Agile methodology is not routinely used to develop medical devices with implantable hardware because of the increased regulatory burden of the need to conduct animal and human studies. Here, we provide the pros and cons of the Waterfall methodology and make a case for adopting the Agile methodology in developing medical devices with physical components. We utilize a peripheral nerve interface as an example device to illustrate the use of the Agile approach to develop neurotechnologies.

Supplementation of dietary nano zinc phytogenic on growth performance and carcass traits of the growing Kampung Unggul Balitbangtan chickens

The objective of this experiment was to evaluate productive performance during the growing period in Kampung Unggul Balitbangtan (KUB) chickens fed on low- and high-nutrient diets containing different levels of dietary nano zinc phytogenic (NZP). The experiment followed a randomized 2 × 6 factorial design, with nutritional content of the diet (high vs low), and dietary NZP (0, 30, 60, 90, 120, or 150 mg Zn/kg) as factors. Each treatment was repeated six times. The feeding trial was carried out until ten weeks of age. Productive performance (feed consumption, FC; body weight gain, BWG; body weight, BW; mortality, feed conversion ratio, FCR; zinc consumption, ZnC; dressing percentage, carcass cut weight; visceral organ weight; and European production efficiency factor, EPEF) was measured. Up to the age of four weeks, dietary NZF dosage impacted BW, BWG, FC, and ZnC. NZP dosage had no effect on mortality. Combination of a high-nutrient diet with 90 mg Zn/kg NZP resulted in the best FCR and EPEF. Up to six weeks, dietary NZP dosage affected BW, BWG, and EPEF. Up to ten weeks of age, addition of NZP (from 30 mg Zn/kg) improved BW, FC, and EPEF. NZP at 30 mg Zn/kg resulted in the best FCR and EPEF. Dietary NZP increased production performance (BW, FC) and economic index (EPEF) in growing KUB chickens fed low- and high-nutrient diets. The recommended use is a high-nutrient diet and 90 mg Zn/kg of NZP.

Seasonal remodeling of visceral organs in the invasive desert gecko Tarentola annularis.

In winter, many reptiles have a period of inactivity ("brumation"). During brumation there is no energetic intake, therefore there would be an advantage to reducing energetic expenditure. The size of energetically costly organs, a major determinant of metabolic rate, is known to be flexible in many tetrapods. Seasonal plasticity of organ size could serve as both an energy-saving mechanism and a source of nutrients for brumating reptiles. We studied a population of an invasive gecko, Tarentola annularis, to test for seasonal changes in activity, metabolic rate, and mass of various organs. The observed period of inactivity was December-February. Standard metabolic rates during the activity season were 1.85 times higher than in brumating individuals. This may be attributed to decreased organ mass during winter: heart mass decreased by 37%, stomach mass by 25%, and liver mass by 69%. Interestingly, testes mass increased by 100% during winter, likely in preparation for the breeding season, suggesting that males prioritize breeding over other functions upon return to activity. The size of the kidneys and lungs remained constant. Organ atrophy occurred only after geckos reduced their activity, so we hypothesize that organ mass changes in response to (rather than in anticipation of) cold winter temperatures and the associated fasting. Degradation of visceral organs can maintain energy demands in times of low supply, and catabolism of the protein from these organs can serve as a source of both energy and water during brumation. These findings bring us closer to a mechanistic understanding of reptiles' physiological adaptations to environmental changes.